首页> 外文期刊>Virchows Archiv: an international journal of pathology >Bcl-2 and Bax expression in thyroid tumours. An immunohistochemical and western blot analysis.
【24h】

Bcl-2 and Bax expression in thyroid tumours. An immunohistochemical and western blot analysis.

机译:Bcl-2和Bax在甲状腺肿瘤中的表达。免疫组织化学和蛋白质印迹分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Bcl-2 and Bax proteins, which are involved in repressing and promoting programmed cell death, respectively, have been investigated immunohistochemically and by Western blot analysis in a series of thyroid tumours. Three immunostaining patterns were identified. Benign lesions and well-differentiated thyroid carcinomas displayed a profile similar to that of normal follicular epithelium, in which Bcl-2 immunostaining was predominant. Thyroid carcinomas associated with an aggressive behaviour, such as the tall-cell variant of papillary carcinoma and the poorly differentiated carcinomas, co-expressed both proteins. Finally, anaplastic carcinomas expressed only the Bax protein. Western blot analyses revealed that the anti-Bcl-2 antibody recognized two bands, of molecular weights 21 kDa and 25 kDa. This was only seen in the tall-cell papillary carcinomas and in the anaplastic carcinomas.
机译:Bcl-2和Bax蛋白分别与抑制和促进程序性细胞死亡有关,已经在一系列甲状腺肿瘤中进行了免疫组织化学和Western blot分析。确定了三种免疫染色模式。良性病变和分化良好的甲状腺癌表现出与正常滤泡上皮相似的特征,其中以Bcl-2免疫染色为主。与侵略性行为相关的甲状腺癌,例如乳头状癌的高细胞变体和分化较差的癌,共表达两种蛋白质。最后,间变性癌仅表达Bax蛋白。蛋白质印迹分析显示抗Bcl-2抗体可识别两条分子量分别为21 kDa和25 kDa的条带。仅在高细胞乳头状癌和间变性癌中可见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号